Cargando…
Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases
BACKGROUND: Hepatic surgery is appropriate for selected patients with colorectal liver metastases (CRLM). Advances in chemotherapy have led to modification of management, particularly when metastases disappear. Treatment should address all initial CRLM sites based on pretherapeutic cross‐sectional i...
Autores principales: | Kepenekian, V., Muller, A., Valette, P. J., Rousset, P., Chauvenet, M., Phelip, G., Walter, T., Adham, M., Glehen, O., Passot, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551408/ https://www.ncbi.nlm.nih.gov/pubmed/31183451 http://dx.doi.org/10.1002/bjs5.50140 |
Ejemplares similares
-
EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types
por: Rigter, Lisanne S., et al.
Publicado: (2019) -
EUS-guided placement of fiducial markers for the treatment of pancreatic cancer
por: Coronel, Emmanuel, et al.
Publicado: (2019) -
The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry
por: Villeneuve, L., et al.
Publicado: (2017) -
Endoscopic ultrasound-guided placement of fiducial markers for stereotactic body radiation therapy of pancreatic metastases from renal cell carcinoma
por: Polkowski, Marcin, et al.
Publicado: (2023) -
Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT
por: Iocolano, Michelle, et al.
Publicado: (2020)